Researchers have found evidence that could help explain why some anemic CKD patients are resistant to treatment with erythropoiesis stimulating agents. Patients on high-dose ESA had significantly ...
A decade of globalization: Trends in participation of investigators from lower-resource economies in phase III lung cancer trials. Background: Two ESAs (darbepoetin alfa, epoetin alfa) are ...
The Senior Cat works his shifts at the Phoenix Children's Hospital, where he literally offers a paw to anyone who needs him, ...
PHILADELPHIA—The use of intravenous (IV) iron for managing anemia in hemodialysis (HD) patients has increased steadily from 2002 to 2008, even after declines in the use of erythropoiesis stimulating ...
Please provide your email address to receive an email when new articles are posted on . Patients switched to oral vadadustat had hemoglobin levels similar to those on a long-acting ...